Show simple item record

dc.contributor.authorVist, Gunn Elisabethnb_NO
dc.contributor.authorHagen, Kåre Birgernb_NO
dc.contributor.authorDevereaux, P Jnb_NO
dc.contributor.authorBryant, Diannenb_NO
dc.contributor.authorKristoffersen, Doris Tovenb_NO
dc.contributor.authorOxman, Andrew Davidnb_NO
dc.date.accessioned2008-03-07T15:31:44Znb_NO
dc.date.accessioned2016-02-08T14:19:55Z
dc.date.available2008-03-07T15:31:44Znb_NO
dc.date.available2016-02-08T14:19:55Z
dc.date.issued2005-05-21nb_NO
dc.identifier.citationBMJ 2005, 330 (7501):1175en
dc.identifier.issn1468-5833nb_NO
dc.identifier.urihttp://hdl.handle.net/11250/2377960
dc.description.abstractOBJECTIVE: To systematically compare the outcomes of participants in randomised controlled trials (RCTs) with those in comparable non-participants who received the same or similar treatment. DATA SOURCES: Bibliographic databases, reference lists from eligible articles, medical journals, and study authors. REVIEW METHODS: RCTs and cohort studies that evaluated the clinical outcomes of participants in RCTs and comparable non-participants who received the same or similar treatment. RESULTS: Five RCTs (six comparisons) and 50 cohort studies (85 comparisons) provided data on 31,140 patients treated in RCTs and 20,380 comparable patients treated outside RCTs. In the five RCTs, in which patients were given the option of participating or not, the comparisons provided limited information because of small sample sizes (a total of 412 patients) and the nature of the questions considered. 73 dichotomous outcomes were compared, of which 59 reported no statistically significant differences. For patients treated within RCTs, 10 comparisons reported significantly better outcomes and four reported significantly worse outcomes. Significantly heterogeneity was found (I2 = 89%) among the comparisons of 73 dichotomous outcomes; none of our a priori explanatory factors helped explain this heterogeneity. The 18 comparisons of continuous outcomes showed no significant differences in heterogeneity (I2 = 0%). The overall pooled estimate for continuous outcomes of the effect of participating in an RCT was not significant (standardised mean difference 0.01, 95% confidence interval -0.10 to 0.12). CONCLUSION: No strong evidence was found of a harmful or beneficial effect of participating in RCTs compared with receiving the same or similar treatment outside such trials.en
dc.language.isoengen
dc.subjectRandomized Controlled Trials as Topicen
dc.subjectTreatment Outcomeen
dc.subject.meshRandomized Controlled Trials as Topicnb_NO
dc.subject.meshRisk Factorsnb_NO
dc.titleSystematic review to determine whether participation in a trial influences outcome.en
dc.typeJournal articleen
dc.source.journalBMJ (Clinical research ed.)en
dc.identifier.doi10.1136/bmj.330.7501.1175nb_NO
dc.identifier.pmid15905256nb_NO
dc.contributor.departmentNorwegian Health Services Research Centre, PO Box 7004, 0130 Oslo, Norway. gev@nhsrc.noen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record